Review of hepatobiliary contrast agents: Current applications and challenges
Alex Frydrychowicz – 31 January 2018
Risk factors for progression of and treatment options for NAFLD in children
Phillipp Hartmann, Bernd Schnabl – 31 January 2018
Risk factors for progression of and treatment options for NAFLD in children
Phillipp Hartmann, Bernd Schnabl – 31 January 2018
Correction
31 January 2018
Imaging features of hepatic arterial and venous flow abnormalities
Abigail Mills, Vincent Mellnick – 31 January 2018
Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial
Norman L. Sussman, James H. Kelly – 31 January 2018
Clinical studies investigating the effect of vitamin E therapy in patients with NASH
- Read more about Clinical studies investigating the effect of vitamin E therapy in patients with NASH
Sebastian Larion, Sandeep Khurana – 31 January 2018
Review of hepatobiliary contrast agents: Current applications and challenges
Alex Frydrychowicz – 31 January 2018
Intra‐arterial locoregional therapy in the management of hepatocellular carcinoma
Meera Ramanathan, Anil Seetharam – 31 January 2018
Intra‐arterial locoregional therapy in the management of hepatocellular carcinoma
Meera Ramanathan, Anil Seetharam – 31 January 2018